Bayer calls for deregulation as healthcare reform cost it €300 million
This article was originally published in Scrip
Executive Summary
Instead of putting the squeeze on innovation, Bayer wants to see more deregulation and reforms that stimulate competition, the firm told Scrip. Global healthcare reform cost the firm €300 million in 2011, with the biggest impact coming from the US and Germany, it said.